Collaborative influenza vaccine innovation centers (civics) - component c: clinical core initial award: september 16, 2019 - september 15, 2021
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00055
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,253,682
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA2018 Solicitation number
- Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Jun 1, 2018
- Contract value 16% obligated
-
- $33,253,682.42 Current, with exercised options
- $210,661,669.92 Potential, with all options
- Completion date 64% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $17,401 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,881,550 | |
| Supplemental Agreement for work within scope | $83,174 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $767,288 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $305,661 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $944,452 | |
| Exercise an Option | $1,172,404 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $848,936 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $866,872 | |
| Supplemental Agreement for work within scope | $1,436,438 | |
| Exercise an Option | $4,991,772 | |
| Exercise an Option | $305,661 | |
| Vendor Address Change | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $828,793 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,340,903 | |
| Exercise an Option | $810,557 | |
| Exercise an Option | $1,566,239 | |
| Exercise an Option | $4,154,512 | |
| Exercise an Option | $7,351,556 | |
| Original award | $2,579,515 |
Show all 31
About this award
The National Institute of Allergy and Infectious Diseases awarded a $210.661 million definitive contract to University Of Maryland, Baltimore on September 16, 2019, for the Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component C: Clinical Core, with an ultimate completion date of September 15, 2030, under cost-no-fee pricing and no set-aside.
Place of performance is Baltimore, MD. The originating solicitation calls for design and execution of clinical trials and human challenge models supporting NIAID's influenza vaccine innovation mission. The contract spans a base period from September 16, 2019, through September 15, 2021, with options extending through September 2030.
Subcontractors include Vanderbilt University Medical Center and The Research Foundation For The State University Of New York (Upstate Medical Center), both engaged in clinical trial design, execution, and human challenge model work awarded at multiple dates from January 2023 through November 2025.
Under Service Contract Inventory reporting, the prime awardee invoiced $22.6 million across FY2020–FY2025 (covering $2 thousand in FY2020, $1.6 million in FY2021, $4.9 million in FY2022, $3.8 million in FY2023, $3.3 million in FY2024, and $7 million in FY2025). The most recent fiscal year (FY2025) reflects 6.1 FTEs across 12,780 contractor hours with a derived government-paid hourly rate of $544.68/hr. Subcontractors delivered 25 percent of FY2025 contractor hours across four named sub-vendors. Pricing and labor intensity have fluctuated significantly year-over-year; FY2024 shows an anomalously low derived rate of $14.55/hr, reflecting either invoice timing or scope shifts, while FY2025 reflects sharp rate elevation and reduced FTE count relative to FY2024's 108 FTEs.
Subawards
Show all 11
Quick answers
Who was awarded contract 75N93019C00055?
75N93019C00055 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2019.
How much is contract 75N93019C00055 worth?
The government has obligated $33,253,682 on 75N93019C00055. Its potential value, with all options, is $210,661,670.
Was contract 75N93019C00055 competed?
The extent of competition for 75N93019C00055 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award